GDRX — Goodrx Holdings Income Statement
0.000.00%
Last trade - 00:00- $1.68bn
- $1.73bn
- $792.32m
- 98
- 46
- 35
- 62
Annual income statement for Goodrx Holdings, fiscal year end - December 31st, USD millions except per share, conversion factor applied.
2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | 2024 December 31st | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
| Source: | 10-K | 10-K | 10-K | 10-K | 10-K |
| Standards: | USG | USG | USG | USG | USG |
| Status: | Final | Final | Final | Final | Final |
| Revenue | |||||
| Total Revenue | 551 | 745 | 767 | 750 | 792 |
| Cost of Revenue | |||||
| Gross Profit | 521 | 699 | 701 | 683 | 744 |
| Selling / General / Administrative Expenses | |||||
| Research And Development | |||||
| Depreciation and Amortization | |||||
| Unusual Expense / Income | |||||
| Total Operating Expenses | 826 | 732 | 765 | 781 | 731 |
| Operating Profit | -276 | 13.4 | 1.74 | -31 | 61.1 |
| Total Net Non Operating Interest Income / Expense | |||||
| Other Net Non Operating Costs | |||||
| Net Income Before Taxes | -303 | -10.2 | -23.2 | -55.6 | 31.5 |
| Provision for Income Taxes | |||||
| Net Income After Taxes | -294 | -25.3 | -32.8 | -8.87 | 16.4 |
| Net Income Before Extraordinary Items | |||||
| Net Income | -294 | -25.3 | -32.8 | -8.87 | 16.4 |
| Income Available to Common Shareholders Excluding Extraordinary Items | |||||
| Income Available to Common Shareholders Including Extraordinary Items | |||||
| Diluted Net Income | -294 | -25.3 | -32.8 | -8.87 | 16.4 |
| Diluted Weighted Average Shares | |||||
| Basic EPS Including Extraordinary Items | |||||
| Diluted EPS Including Extraordinary Items | |||||
| Diluted EPS Excluding Extraordinary Items | |||||
| Normalised Income Before Taxes | |||||
| Normalised Income After Taxes | |||||
| Normalised Income Available to Common Shareholders | |||||
| Diluted Normalised EPS | -1.07 | -0.039 | -0.024 | 0.049 | 0.078 |
| Dividends per Share |